Evidence map›Paper›PMID 37023171›Full record

ArticleScience (New York, N.Y.)2023

Structure of the R2 non-LTR retrotransposon initiating target-primed reverse transcription.

Max E Wilkinson, Chris J Frangieh, Rhiannon K Macrae, Feng Zhang

Open access · hybridAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
28.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. DNA-bound avian R2 non-LTR retrotransposon protein recruits a second R2 protein for genome-protective second-strand nicking.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. In Vivo CAR-T Therapies-A New Era of Programmable Immunity.International journal of molecular sciences · 2026
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Max E WilkinsonHoward Hughes Medical Institute, Cambridge, MA 02139, USA.ORCID 0000-0003-4738-9503
Chris J FrangiehHoward Hughes Medical Institute, Cambridge, MA 02139, USA.
Rhiannon K MacraeHoward Hughes Medical Institute, Cambridge, MA 02139, USA.ORCID 0000-0002-7850-9056
Feng ZhangHoward Hughes Medical Institute, Cambridge, MA 02139, USA.ORCID 0000-0003-0178-7995
Broad Institute · US

Funding

Programmable RNA-targeting toolsR01HG009761 · NHGRI · BROAD INSTITUTE, INC. · PI ZHANG, FENG · 2017 to 2024
$7.5M
Howard Hughes Medical InstituteNHGRI NIH HHS R01 HG009761
6 · The paper itself

Abstract

Non-long terminal repeat (non-LTR) retrotransposons, or long interspersed nuclear elements (LINEs), are an abundant class of eukaryotic transposons that insert into genomes by target-primed reverse transcription (TPRT). During TPRT, a target DNA sequence is nicked and primes reverse transcription of the retrotransposon RNA. Here, we report the cryo-electron microscopy structure of the

Indexed as

Long Interspersed Nucleotide ElementsReverse TranscriptionRNA-Directed DNA PolymeraseBombyxCryoelectron MicroscopyInsect ProteinsInsect ProteinsR2 reverse transcriptase, Bombyx moriRNA-Directed DNA Polymerase

Identifiers

PMID37023171
PMCPMC10499050
OpenAlexW4362677102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.